Back to Journals » Drug Design, Development and Therapy » Volume 16

Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights

Total article views   HTML views PDF downloads Totals
4,227 Dovepress* 4,169+ 266 4,435
PubMed Central* 58 36 94
Totals 4,227 302 4,529
*Since 16 May 2022

View citations on PubMed Central and Google Scholar